HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 2006-0736v1 25/8/2006    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ustanina, S. Articles by Braun, T. Search for Related Content PubMed PubMed Citation Articles by Ustanina, S. Articles by Braun, T.

TISSUE-SPECIFIC STEM CELLS

The Myogenic Factor Myf5 Supports Efficient Skeletal Muscle Regeneration by Enabling Transient Myoblast Amplification

^aMax Planck Institute for Heart and Lung Research, Department of Cardiac Development and Remodeling, Bad Nauheim, Germany;
^bSection of Gene Function and Regulation, The Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom

Key Words. Muscle regeneration • Myf5 • Satellite cells • Stem cells • Muscle differentiation

Correspondence: Thomas Braun, M.D., Ph.D., Max Planck Institute for Heart and Lung Research, Department of Cardiac Development and Remodeling, Parkstrasse 1, 61231 Bad Nauheim, Germany. Telephone: 49-6032-705-401; e-mail: thomas.braun{at}kerckhoff.mpg.de

Received November 13, 2006; accepted for publication May 4, 2007.
First published online in STEM CELLS EXPRESS   May 10, 2007.



The myogenic factor Myf5 defines the onset of myogenesis in mammals during development. Mice lacking both Myf5 and MyoD fail to form myoblasts and are characterized by a complete absence of skeletal muscle at birth. To investigate the function of Myf5 in adult skeletal muscle, we generated Myf5 and mdx compound mutants, which are characterized by constant regeneration. Double mutant mice show an increase of dystrophic changes in the musculature, although these mice were viable and the degree of myopathy was modest. Myf5 mutant muscles show a small decrease in the number of muscle satellite cells, which was within the range of physiological variations. We also observed a significant delay in the regeneration of Myf5 deficient skeletal muscles after injury. Interestingly, Myf5 deficient skeletal muscles were able to even out this flaw during the course of regeneration, generating intact muscles 4 weeks after injury. Although we did not detect a striking reduction of MyoD positive activated myoblasts or of Myf5-LacZ positive cells in regenerating muscles, a clear decrease in the proliferation rate of satellite cell-derived myoblasts was apparent in satellite cell-derived cultures. The reduction of the proliferation rate of Myf5 mutant myoblasts was also reflected by a delayed transition from proliferation to differentiation, resulting in a reduced number of myotube nuclei after 6 and 7 days of culture. We reason that Myf5 supports efficient skeletal muscle regeneration by enabling transient myoblast amplification.

Disclosure of potential conflicts of interest is found at the end of this article.

This article has been cited by other articles:

				N. Gensch, T. Borchardt, A. Schneider, D. Riethmacher, and T. Braun Different autonomous myogenic cell populations revealed by ablation of Myf5-expressing cells during mouse embryogenesis Development, May 1, 2008; 135(9): 1597 - 1604. [Abstract] [Full Text] [PDF]

				C. E. Holterman, F. Le Grand, S. Kuang, P. Seale, and M. A. Rudnicki Megf10 regulates the progression of the satellite cell myogenic program J. Cell Biol., December 3, 2007; 179(5): 911 - 922. [Abstract] [Full Text] [PDF]

				F. Le Grand and M. Rudnicki Satellite and stem cells in muscle growth and repair Development, November 15, 2007; 134(22): 3953 - 3957. [Abstract] [Full Text] [PDF]